Company Filing History:
3 out of 528 
1 out of 1 Years Active: 1999-2010
Title: Giandomenico Russo: Innovator in Genetic Research
Introduction
Giandomenico Russo is a prominent inventor based in Rome, Italy. He has made significant contributions to the field of genetic research, particularly in the study of the TCL-1 gene and its associated proteins. With a total of three patents to his name, Russo's work has implications for diagnostics and therapeutics in various disease states.
Latest Patents
Russo's latest patents include groundbreaking inventions related to the TCL-1 gene and protein. The first patent focuses on nucleotide sequences of TCL-1 genes and the amino acid sequences of their encoded proteins, along with derivatives, analogs, and antibodies. This invention highlights the preferential expression of the TCL-1 gene during early T and B lymphocyte differentiation. Furthermore, it discusses the potential use of TCL-1 genes and their proteins as diagnostic and therapeutic reagents for diseases associated with chromosomal abnormalities. The second patent reiterates these findings, emphasizing the importance of TCL-1 in medical applications.
Career Highlights
Throughout his career, Giandomenico Russo has worked with esteemed institutions, including Thomas Jefferson University and Raggio-italgene S.p.a. His research has been pivotal in advancing our understanding of genetic markers and their roles in health and disease.
Collaborations
One of Russo's notable collaborators is Carlo M. Croce, a respected figure in the field of cancer research. Their partnership has contributed to the advancement of knowledge regarding genetic factors in disease.
Conclusion
Giandomenico Russo's innovative work in genetic research, particularly concerning the TCL-1 gene, showcases his dedication to advancing medical science. His patents reflect a commitment to developing diagnostic and therapeutic solutions for complex health issues.